| Literature DB >> 35490178 |
Napaporn Tananuvat1, Sasiwimon Tansanguan1, Nahathai Wongpakaran2, Tinakon Wongpakaran3.
Abstract
This hospital-based, cross-sectional observational study aimed to examine whether neuroticism has an impact on stress that is related to dry eye disease (DED) and quality of life (QOL). One hundred participants who had DED completed the Dry Eye-Related Quality-of-Life Score (DEQS) questionnaire, a 5-level EQ-5D (EQ-5D-5L), Neuroticism Inventory (NI), and 10-Item Perceived Stress Scale (PSS). Hierarchical linear regression was applied to determine the predictive effect of the independent variables. Participants' mean age was 50.91 ± 14.3 years, and females totalled 89.0%. Hierarchical linear regression analysis showed that DESQ-Ocular symptoms were the strongest predictor for QOL either assessed by DEQS or EQ-5D, and its effect was lessened when perceived stress and neuroticism were added to the model. The final model explained up to 30-39% variance of the QOL, compared with 13-32% by DESQ-Ocular symptoms alone. QOL of the patients with DED, is not only related to eye symptoms but perceived stress. Moreover, neuroticism was a strong predictor contributing to the QOL among patients with DED. The study showed a significant association between perceived stress, neuroticism and the QOL of patients with DED. Personality has some impact on both subjective dry eye symptoms and impact on daily life, along with the general health-related QOL.Entities:
Mesh:
Year: 2022 PMID: 35490178 PMCID: PMC9056508 DOI: 10.1038/s41598-022-11271-z
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.996
Demography and characteristics of participants with DED (N = 100).
| Characteristic | N (%) |
|---|---|
| Mean ± SD | 50.9 ± 14.36 |
| Range | 20–84 |
| Sex: female | 89 (89.0%) |
| Dry eye | 75 (75%) |
| Cataract | 11 (11%) |
| Pterygium | 10 (10%) |
| Pinguecula | 2 (2%) |
| Glaucoma | 1 (1%) |
| Hypertension | 23 (23%) |
| Dyslipidemia | 18 (18%) |
| Allergy | 16 (16%) |
| Systemic lupus erythematosus | 8 (8%) |
| Diabetes mellitus | 5 (5%) |
| Inactive cancer | 5 (5%) |
| Miscellaneous* | 14 (14%) |
| Regular exercise | 42 (42%) |
| Contact lens wear | 4 (3.8%) |
| Smoking | 2 (2.0%) |
| Summary score | 43.7 ± 19.8 |
DED dry eye disease, SD standard deviation, DEQS Dry Eye-related Quality-of-Life Score, *Hypothyroidism (4), gout (2), osteoporosis (2), chronic kidney disease (1), polycystic ovarian syndrome (1), migraine (1), anemia (1), coronary artery disease (1), Gastroesophageal reflux disease (1).
Mean score of each item of the DEQS-TH and the correlations with age, sex, NI and PSS scores using Pearson’s among participants with DED.
| Mean ± SD | Cronbach | 1 | 2 | 3 | 4 | 5 | 6 | 7 | |
|---|---|---|---|---|---|---|---|---|---|
| 1. Sex, female | – | – | – | 0.096 | 0.061 | − 0.054 | 0.044 | 0.109 | 0.091 |
| 2. Age | 50.91 ± 14.36 | – | – | − 0.023 | − 0.205* | 0.022 | 0.138 | − 0.039 | |
| 3. NI score | 31.67 ± 9.10 | 0.905 | – | 0.472** | 0.317** | 0.415** | 0.480** | ||
| 4. PSS score | 18.53 ± 6.09 | 0.803 | – | 0.320** | 0.402** | 0.437** | |||
| 5. Eye symptoms | 18.46 ± 6.10 | 0.901 | – | 0.650** | 0.350** | ||||
| 6. Impact on Daily Life | 45.44 ± 22.01 | 0.954 | – | 0.499** | |||||
| 7. EQ_5D index value | 0.86 (0.22)† | 0.740 | – |
DEQS Dry Eye-related Quality-of-Life Score, SD standard deviation, DED dry eye disease, NI Neuroticism Inventory, PSS Perceived Stress Scale, EQ-5D EuroQoL-5 dimension, *p < 0.05, **p < 0.01, ***p < 0.001, †median (interquartile range).
Hierarchical multiple regression analyses predicting QOL score of DEQS-Th and EQ-5D from DEQS-Ocular symptoms, perceived stress, and neuroticism scores.
| Step | Variable | Impact on daily life | EQ-5D | ||||
|---|---|---|---|---|---|---|---|
| R2 adj | R2 change | B (95% CI) | R2 adj | R2 change | B (95% CI) | ||
| 1 | 0.018 | 0.028 | 0.039 | 0.002 | |||
| Age | − 0.258 (− 0.561, 0.045) | − 0.001 (− 0.006, 0.004) | |||||
| 2 | 0.323 | 0.308*** | 0.130 | 0.128** | |||
| Age | − 0.029 (− 0.289, 0.231) | 0.002 (− 0.003, 0.007) | |||||
| DESQ-Ocular Symptoms | 2.073*** (1.46, 2.686) | 0.024** (0.001, 0.010) | |||||
| 3 | 0.370 | 0.052** | 0.236 | 0.133*** | |||
| Age | 0.020 (− 0.234, 0.273) | 0.004 (− 0.001, 0.008) | |||||
| DESQ-Ocular Symptoms | 1.823*** (1.207, 2.440) | 0.018*** (0.005, 0.030) | |||||
| PSS-10 | 0.878** (0.268, 1.488) | 0.023** (− 0.017, 0.007) | |||||
| 4 | 0.391 | 0.027* | 0.300 | 0.069* | |||
| Age | − 0.015 (− 0.267, 0.236) | 0.002 (− 0.002, 0.001) | |||||
| DESQ-Ocular Symptoms | 1.678*** (1.056, 2.300) | 0.014* (0.002, 0.026) | |||||
| PSS-10 | 0.582 (− 0.081, 1.244) | 0.015* (0.002, 0.028) | |||||
| NI-15 | 0.461* (0.022, 0.901) | 0.012** (0.004, 0.020) | |||||
QOL quality of life, DEQS-Th Thai version of Dry Eye-related Quality-of-Life Score, EQ-5D EuroQoL-5 dimension, adj adjusted, R coefficient r, R adj adjusted R square, B unstandardized Coefficients, PSS Perceived Stress Scale, NI Neuroticism Inventory, *p < 0.05, **p < 0.01, ***p < 0.001.